Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

283 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Relevance of motor complications in Parkinson's disease.
Adler CH. Adler CH. Neurology. 2002 Feb 26;58(4 Suppl 1):S51-6. doi: 10.1212/wnl.58.suppl_1.s51. Neurology. 2002. PMID: 11909985 Review.
Tourette's syndrome. Current approaches to recognition and management.
Dodick D, Adler CH. Dodick D, et al. Among authors: adler ch. Postgrad Med. 1992 Oct;92(5):299-302, 305-8. doi: 10.1080/00325481.1992.11701499. Postgrad Med. 1992. PMID: 1357638
Olfactory function in Parkinson's disease subtypes.
Stern MB, Doty RL, Dotti M, Corcoran P, Crawford D, McKeown DA, Adler C, Gollomp S, Hurtig H. Stern MB, et al. Among authors: adler c. Neurology. 1994 Feb;44(2):266-8. doi: 10.1212/wnl.44.2.266. Neurology. 1994. PMID: 8309571
Adjunctive cabergoline therapy of Parkinson's disease: comparison with placebo and assessment of dose responses and duration of effect.
Ahlskog JE, Wright KF, Muenter MD, Adler CH. Ahlskog JE, et al. Among authors: adler ch. Clin Neuropharmacol. 1996 Jun;19(3):202-12. doi: 10.1097/00002826-199619030-00002. Clin Neuropharmacol. 1996. PMID: 8726539 Clinical Trial.
Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's disease.
Hutton JT, Koller WC, Ahlskog JE, Pahwa R, Hurtig HI, Stern MB, Hiner BC, Lieberman A, Pfeiffer RF, Rodnitzky RL, Waters CH, Muenter MD, Adler CH, Morris JL. Hutton JT, et al. Among authors: adler ch. Neurology. 1996 Apr;46(4):1062-5. doi: 10.1212/wnl.46.4.1062. Neurology. 1996. PMID: 8780092 Clinical Trial.
Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson's disease experiencing motor fluctuations: a multicenter, double-blind, randomized, placebo-controlled trial. Tolcapone Fluctuator Study Group I.
Kurth MC, Adler CH, Hilaire MS, Singer C, Waters C, LeWitt P, Chernik DA, Dorflinger EE, Yoo K. Kurth MC, et al. Among authors: adler ch. Neurology. 1997 Jan;48(1):81-7. doi: 10.1212/wnl.48.1.81. Neurology. 1997. PMID: 9008498 Clinical Trial.
Treatment of restless legs syndrome with gabapentin.
Adler CH. Adler CH. Clin Neuropharmacol. 1997 Apr;20(2):148-51. doi: 10.1097/00002826-199704000-00006. Clin Neuropharmacol. 1997. PMID: 9099467 Clinical Trial.
Amantadine in advanced Parkinson's disease: good use of an old drug.
Adler CH, Stern MB, Vernon G, Hurtig HI. Adler CH, et al. J Neurol. 1997 May;244(5):336-7. doi: 10.1007/s004150050098. J Neurol. 1997. PMID: 9178162 No abstract available.
Ropinirole for the treatment of early Parkinson's disease. The Ropinirole Study Group.
Adler CH, Sethi KD, Hauser RA, Davis TL, Hammerstad JP, Bertoni J, Taylor RL, Sanchez-Ramos J, O'Brien CF. Adler CH, et al. Neurology. 1997 Aug;49(2):393-9. doi: 10.1212/wnl.49.2.393. Neurology. 1997. PMID: 9270567 Clinical Trial.
Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patients.
Uitti RJ, Wharen RE Jr, Turk MF, Lucas JA, Finton MJ, Graff-Radford NR, Boylan KB, Goerss SJ, Kall BA, Adler CH, Caviness JN, Atkinson EJ. Uitti RJ, et al. Among authors: adler ch. Neurology. 1997 Oct;49(4):1072-7. doi: 10.1212/wnl.49.4.1072. Neurology. 1997. PMID: 9339692
283 results
Jump to page
Feedback